Scientific American’s Worldview 100 ranks Dr. Collins among the top 10 visionaries in biotechnology for advancing the field through his leadership. Scientific American worldVIEW. 2015.
NIAID Director Anthony S. Fauci, M.D., and NIH Director Francis S. Collins, M.D., Ph.D., address the importance of continuing to pursue research on a global scale amid fiscal constraints. Science; 348, 6231; 159. April 9, 2015.
For Reuters, Dr. Collins highlights challenges and opportunities of piecing together existing data for the precision medicine program. Reuters. March 6, 2015.
NIH Director Francis S. Collins, M.D., Ph.D. and NCI Director Harold Varmus, M.D. explain the scientific justification for the Precision Medicine Initiative in a perspective for the New England Journal of Medicine.N Engl J Med; 372:793-795. Online: January 30, 2015. In print: February 26, 2015.
In a JAMA Viewpoint, Dr. Collins highlights areas of research showing great promise for advancing biomedical research and technology, treatments and therapies, and improving human health. JAMA. January 13, 2015. Volume 313, Number 2.
In AARP Bulletin Dr. Collins highlights biomedical breakthroughs to watch for in 2015, including brain health research, targeted therapy for cancer treatment and vaccines trials. AARP. December 2014/January.
Dr. Collins and NIGMS Director Dr. Jon Lorsch author an article in Science Magazine addressing cell line misidentification in research and suggesting best practices for authentication and verification. Science; 346; 6216: 1452-1453. December 19, 2014.
In a LA Times article, Dr. Collins says he expects the NIH BD2K Initiative to invest $656 million over the next seven years to make biomedical data sets more accessible to researchers. Healy, Melissa. Los Angeles Times. October 9, 2014.
The NIH announced awardees of the initial round of funding for projects under the BRAIN Initiative. Nutt, Amy Ellis. Washington Post. September 30, 2014.
In an interview with Nature, Dr. Collins reflects on the challenges in the current budget climate. Nature. August, 15, 2014.
To commemorate the NIH Common Fund 10 year anniversary, Dr. Collins co-authors an article with former NIH director Dr. Elias Zerhouni and NIH’s Dr. Elizabeth Wilder about why we must continue supporting innovative transdisciplinary science. Collins, F.S., Wilder, E.L., & Zerhouni, E. “NIH Roadmap/Common Fund at 10.” Sciencexpress 19 June 2014: 1-5.
In a Q&A with USA Today, Dr. Collins outlines what medical breakthroughs are on the horizon and how these discoveries will affect health in the future. USA Today. May 15, 2014.
In a Nature Comment, Dr. Collins and Dr. Janine Clayton outline NIH steps to address sex differences in preclinical research. Nature. 509, 282-283 (2014). Published online May 14, 2014.
Dr. Collins and NIH colleagues write an editorial in the Journal of American Medical Informatics Association on taking PCORnet from dream to reality. J Am Med Inform Assoc. Published online May 12, 2014.
In a Washington Post article on PCORI, Dr. Collins talks about how this new medical information repository gives scientists the ability to look at a large patient population with great speed and little cost. The Washington Post. April 15, 2014.
Dr. Collins pens an Op-Ed in The New York Times about the regular use of genetic testing in the near future, and the need to have clear protections and prohibitions around patient privacy and the misuse of test results. The New York Times. April 14, 2014.
Interviewed for Bloomberg News, Dr. Collins discusses researching new therapeutic uses for existing compounds in an effort to treat major diseases. Bloomberg News. April 11, 2014.
In a New York Times’ article and video, Dr. Collins acknowledges the importance of philanthropy in filling budget gaps, but emphasizes the ongoing need for public funding. The New York Times. March 15, 2014.
Dr. Collins has a conversation with AARP Bulletin about the BRAIN Initiative, his role leading the Human Genome Project, and more. AARP Bulletin. March 10, 2014.
In a Boston Globe article on cancer research budget gaps, Dr. Collins talks about the challenges in advancing the science with the current funding climate. Boston Globe. March 9, 2014.
In an interview with ASCO Post, Dr. Collins explains how NIH is focusing on working within its resource constraints to try to keep the engine of discovery moving forward. ASCO Post. March 1, 2014.
The Washington Post Editorial Board supports the Accelerating Medicines Partnership’s goal to find new biomarkers for Alzheimer’s, type 2 diabetes, rheumatoid arthritis and lupus. The Washington Post. February 8, 2014.
In the New York Times, Dr. Collins lauds the Accelerating Medicines Partnership as a unique collaboration which will work towards expediting the identification of new drug targets for three major disease areas. New York Times. February 4, 2014.
In a commentary for Nature, Drs. Collins and Tabak discuss the NIH’s initiatives to improve reproducibility, particularly in preclinical research. Collins, Francis S., and Tabak, Lawrence A. “NIH plans to enhance reproducibility.” Nature 505, 612-613 (27 January 2014).
This page last reviewed on
July 27, 2015